Morning Seminar April 27, 2006

Cancer. 2006 Feb 1;106(3):703-7.

Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma.

Bisogno G, Riccardi R, Ruggiero A, Arcamone G, Prete A, Surico G, Provenzi M, Bertolini P, Paolucci P, Carli M.